| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 10-Q | Report | Data | 10-Q | Nov 7, 2024 | Sep 30, 2024 |
| 8-K | Report | Data | 8-K | Nov 7, 2024 | Nov 7, 2024 |
| SC 13D/A | Report | SC 13D/A | Oct 30, 2024 | |
| 8-K | Report | Data | 8-K | Oct 28, 2024 | Oct 25, 2024 |
| SC 13D/A | Report | SC 13D/A | Sep 24, 2024 | |
| SC 13D/A | Report | NEW ENTERPRISE ASSOCIATES 17, L.P. -- MONTE ROSA THERAPEUTICS 13D/A(#2) | Aug 12, 2024 | |
| SC 13D/A | Report | SC 13D/A | Aug 12, 2024 | |
| 10-Q | Report | Data | 10-Q | Aug 8, 2024 | Jun 30, 2024 |
| 8-K | Report | Data | 8-K | Aug 8, 2024 | Aug 8, 2024 |
| 8-K | Report | Data | 8-K | Jun 27, 2024 | Jun 27, 2024 |
| 8-K | Report | Data | 8-K | Jun 12, 2024 | Jun 12, 2024 |
| 8-K | Report | Data | 8-K | May 30, 2024 | May 28, 2024 |
| 8-K | Report | Data | 8-K | May 16, 2024 | May 15, 2024 |
| SC 13D/A | Report | NEW ENTERPRISE ASSOCIATES 17, L.P. -- MONTE ROSA THERAPEUTICS 13D/A(#1) | May 13, 2024 | |
| 10-Q | Report | Data | 10-Q | May 9, 2024 | Mar 31, 2024 |
| 8-K | Report | Data | 8-K | May 9, 2024 | May 9, 2024 |
| 8-K | Report | Data | 8-K | May 2, 2024 | Apr 29, 2024 |
| SC 13G/A | Report | Apr 10, 2024 | ||
| 10-K | Report | Data | 10-K | Mar 14, 2024 | Dec 31, 2023 |
| 8-K | Report | Data | 8-K | Mar 14, 2024 | Mar 14, 2024 |
| SC 13G | Report | SC 13G | Feb 14, 2024 | |
| SC 13G/A | Report | AMENDMENT NO. 3 | Feb 14, 2024 | |
| SC 13G/A | Report | Feb 14, 2024 | ||
| SC 13G/A | Report | MONTE ROSA THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | Feb 14, 2024 | ||
| SC 13G/A | Report | Feb 9, 2024 | ||
| 8-K | Report | Data | 8-K | Jan 8, 2024 | Jan 8, 2024 |
| SC 13D/A | Report | SC 13D/A | Nov 9, 2023 | |
| 10-Q | Report | Data | 10-Q | Nov 9, 2023 | Sep 30, 2023 |
| 8-K | Report | Data | 8-K | Nov 9, 2023 | Nov 9, 2023 |
| 8-K | Report | Data | 8-K | Oct 26, 2023 | Oct 26, 2023 |
| 8-K | Report | Data | 8-K | Oct 17, 2023 | Oct 16, 2023 |
| 10-Q | Report | Data | 10-Q | Aug 10, 2023 | Jun 30, 2023 |
| 8-K | Report | Data | 8-K | Aug 10, 2023 | Aug 10, 2023 |
| 8-K | Report | Data | 8-K | Jul 26, 2023 | Jul 26, 2023 |
| 8-K | Report | Data | 8-K | Jun 14, 2023 | Jun 14, 2023 |
| 10-Q | Report | Data | 10-Q | May 11, 2023 | Mar 31, 2023 |
| 8-K | Report | Data | 8-K | May 11, 2023 | May 11, 2023 |
| 8-K | Report | Data | 8-K | Mar 23, 2023 | Mar 22, 2023 |
| 10-K | Report | Data | 10-K | Mar 16, 2023 | Dec 31, 2022 |
| 8-K | Report | Data | 8-K | Mar 16, 2023 | Mar 16, 2023 |
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | MONTE ROSA THERAPEUTICS, INC. | Feb 14, 2023 | |
| SC 13G/A | Report | Feb 9, 2023 | ||
| SC 13G | Report | Feb 3, 2023 | ||
| 8-K | Report | Data | 8-K | Jan 9, 2023 | Jan 9, 2023 |
| 10-Q | Report | Data | 10-Q | Nov 10, 2022 | Sep 30, 2022 |
| 8-K | Report | Data | 8-K | Nov 10, 2022 | Nov 10, 2022 |
| 8-K | Report | Data | FORM 8-K | Oct 24, 2022 | Oct 24, 2022 |
| 10-Q | Report | Data | 10-Q | Aug 11, 2022 | Jun 30, 2022 |
| 8-K | Report | Data | 8-K | Aug 11, 2022 | Aug 11, 2022 |
| 8-K | Report | Data | 8-K | Jun 15, 2022 | Jun 15, 2022 |
| 10-Q | Report | Data | 10-Q | May 11, 2022 | Mar 31, 2022 |
| 8-K | Report | Data | 8-K | May 11, 2022 | May 11, 2022 |
| 10-K | Report | Data | 10-K | Mar 29, 2022 | Dec 31, 2021 |
| 8-K | Report | Data | 8-K | Mar 29, 2022 | Mar 29, 2022 |
| SC 13G/A | Report | Feb 14, 2022 | ||
| SC 13G | Report | MONTE ROSA THERAPEUTICS, INC. | Feb 11, 2022 | |
| SC 13G/A | Report | Feb 10, 2022 | ||
| SC 13G | Report | Feb 10, 2022 | ||
| SC 13G/A | Report | Feb 9, 2022 | ||
| SC 13G/A | Report | Feb 9, 2022 | ||
| SC 13G | Report | Feb 4, 2022 | ||
| 8-K | Report | Data | 8-K | Jan 10, 2022 | Jan 10, 2022 |
| 8-K | Report | Data | 8-K | Dec 15, 2021 | Dec 14, 2021 |
| 8-K | Report | Data | 8-K | Nov 12, 2021 | Nov 10, 2021 |
| 10-Q | Report | Data | 10-Q | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | Report | Data | 10-Q | Aug 12, 2021 | Jun 30, 2021 |
| 8-K | Report | Data | FORM 8-K | Aug 12, 2021 | Aug 12, 2021 |
| SC 13G | Report | Aug 10, 2021 | ||
| SC 13D | Report | NEW ENTERPRISE ASSOCIATES 17, L.P. / MONTE ROSA THERAPEUTICS, INC. -- SCHEDULE 1 | Jul 12, 2021 | |
| SC 13D | Report | SC 13D | Jul 8, 2021 | |
| SC 13G | Report | Jul 8, 2021 | ||
| 8-K | Report | 8-K | Jun 28, 2021 | Jun 28, 2021 |